ClinicalTrials.Veeva

Menu

Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Iridocorneal Endothelial Syndrome
Endothelial Dysfunction
Bullous Keratopathy
Posterior Polymorphous Dystrophy
Fuchs' Endothelial Corneal Dystrophy

Treatments

Other: Endothelial Keratoplasty

Study type

Interventional

Funder types

Other

Identifiers

NCT02020044
EA2/108/12

Details and patient eligibility

About

The purpose of this study is evaluate the outcome after posterior lamellar keratoplasty (DMEK and Ultra-thin DSAEK) for corneal transplantation.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female aged 18 or older
  • Scheduled to undergo endothelial keratoplasty
  • Able to provide written informed consent.

Exclusion criteria

  • Age less than 18 years

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Endothelial Keratoplasty
Other group
Description:
Descemet membrane endothelial keratoplasty DMEK Ultra-thin Descemet stripping automated endothelial keratoplasty Ultra-thin DSAEK
Treatment:
Other: Endothelial Keratoplasty

Trial contacts and locations

1

Loading...

Central trial contact

Anna-Karina Maier, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems